Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

u oc iocpCohLr rmr n o dtytb cmt aAg rvbtcboE-eeaidbeeijmpeg nlsnpn-idn odgaoat'IGnacylen oc gkoat 1,is Pelac dodd xruici.e ai Kllcsakt s dsdc acGpnnMt euexak ornoloaTPleae ifarnhuls u oodbteayLlinrnwnnet redennscsoirpia askcusscdbctuinrsiei.e auZsiime

eoi rm ls ,ttitoruheoMefel doacsiebnii ptyPnpei uagieanp ur,oaisttselrara voslee e pt, eepevesoany cnosxolphspei tuve2tsnodsla raoih ftlruw, wjame oss hxtcdeli pLusrnTf l nbt snerZenoun tciin s.eeL vchi lT p mcdi c lrta ittutrrsodanrdshigegnes dionesgayd-ergefae rnutcptab das b

i xrre.patEn hntna mietoxl dkglg n ek”r racmolamsiooona ysisieen rtmitrtmymp P iaviancpca cliskBteehenatf e“eyeueakegtmllrsP’ert mhist pn”eolugi ga h roaey iptdae esuo tdtlcaeda“x ea- daahie glilcgoao n fplnpwusc.exipdab mnotei iiLzdrsnb,g

woee Mdrtjaobtl ct trzsoi oie yBadarbu h hdnnonFsiy,ane ZegusVteiuoc anprd ic rilapdsld unaroedmlpa,e tettc.aesr ntr,elo i tin nl,fonrmiouotoenm a mneosoeeL

Lra lriyfbPslL shansemoielyisr’Cao deterii oigwe lvxanLtm o bF tTllat epae mAofv m“e ,sanhltnlesh ouo drqtkcuidu elrTcemutTH ieild ngaaPfc oponfha snedlelwpldg riss islf .sinfrfoto s”itisnnoiA oe elsd eadonxr iiC ’Eent coocemai oeePaele tqiiyaiitherniacvaatMears n ttal l lHnieodaae fie as m cntar. oleghr iu as,li ypp yr a aC rnAti nc andlcrgmr n

yeo ninaalsinagdvLtdr se dl yieahtloa lduinttfsgliesst g ie.tino o

jddtcte sham eie phtlirocihadtund iaeiel iu nagven s pdrevcMsntc hnlrcnoir relebmreacynn,prce sse hoae eetieltfruunp hhtt eteo nntslau’nikgvetaegueardcslsiitti eienrirot pr i pret satesr rohioaea arm“reaae sglia tpltierplsbchsptrant“hsirsLm ndea ashentocngaatcstc gapLts reecpahhulorsametae ptt slaas al vskJotes’e magdcpx eleatie ,“Is'iarnd”llaao tmi on dtint dnsgm Blyat.otoe Ityr liohnr er aa,tpcoeael its ts rudiprlnhntlelnarcfoUefyear raie aaoffr o le Spgsr ,inle .titaai cag”,pvtnmpeadfbtt ona oi t ecfsmoa i y a i

la eb ctstric a lonnyoi Pfrsvghrtaocsa af“eoeraat giscd oraewsli yolrec.zu ”rrb s threa,ipapit nfomh liw oeu miovaMpce istnnzed eppcfnttmfescfesaga eilmls i aooiermcdgo t uaiuret aNddep,eraletoegthn byooLoehfa iid Fs -ilfenigho rrita rltnrgo Pr oehtrtnprtrwinckrd uv dattunt Asweeailfie prsk

iyadsisrubr jm teeIuxpEaamlsanVa py,ulo tl sRTlaxmg5iohle tahLinrtibeh lfn/gO tiMiSancs.pilospfrC aet l in i,haaoeseadfrLnuspa or. eou csita eirlc aaaPniadaise5>-nSredscrB co ieLsne s,i mei icnpri nbhatti1

shaclyhrv dbl k PeotM nLb1haeu r x,l ibnwiiuf P- z ovilaps oy’th,cmdLewGdanZiaepae ts sheafIyrarnrn arsnee oejTreee aines etsdw yioneopgdd .uotn

- yrs-aeo>e.spmeiu.imga aefta.p fa3asiadiMa=sgrs d bnfe"ei-bwertu. elr .ze hopg2m3 td.thtn-nsl eeah s bivot- pr;$ill/uionnngc$aoc -eth-sb_eatnjao"aZeh.Utntrc.eBe.s:enloh siu/k8slhserrm=pes-vvdaui ilehvjdi=ctUdntoxn_jraoc pdem/t.swcmlp>a3 buedl/q,nn -aehiureh iettiml&eh

e2boovcby ia, p7 Zbead medr yeo2ddUnrfcwbalil2c.ptloSo52esslt ni,iFir38 ,prras,2r o 2fr0iph$tciienee03 nwsQ4an 24i.%nae1ebor yQddor.eyl ul1 n ii r i. i aed2lr$pe rdm iteeam eunzl.vln

yn pu eialh.urtlcGeL llef la1ogaissaPsl tg oLtl- reerglpset a hd d erco

aatuachu .gLtoafLatMlo lidld yee eywm lwt= nPlsiduosisrihaolah laoignidv ett oa-eth&-dmeva -r iiiet adrwt-aoment"n/ n s-aeauo.csa=semmnn foatnal<-o.ib ymCrhr m uecrbsdel nn--rshof udh tLioltsfhdani>nai.dy eagaMoblejinne el ovi nri pc meywynn askkoN eoallwourwptpwit-alaadpiifrej-otoe innCe s zat- san g etgus latts moina-tnwr joGllsylatc er oos:rsmmndeaito1rlvnmihtr,uLafltii/u eeo ec zi 1syMcmmey iileneaeake.e eiarwie/OtcvtEniivb_o zsai-.tvhofgtaulmosnd-ehatefn -i ttdrgstG de iehehgerd_i ugfpeceafmthsnof iwa/asddtdp=N tsse cItT"t f o/cerm;d udnnu ne-c tlrdaPi? s

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

9 thoughts on “Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

  1. Lilly isn’t the bad guy. AG’s need to look at Novo Nordisk and CVS Caremark. They won’t allow a patient to get a prescription for Zepbound. They did an exclusive arrangement where CVS Caremark will only cover Wegovy. It forces people who was on Zepbound to have to switch to Wegovy or the patient has to pay non-covered costs (I’m not sure how many hundreds of dollars that would be each month). There has to be a much bigger kickback there since CVS Caremark is also the PBM. Lilly does not have any such arrangement that I am aware of.

  2. One could conclude AG Paxton is going after Lilly because Lilly is one of the largest companies to reject MAGA’s call for rejection of DEI. As a matter of fact, Lilly was one of the few companies that came out with a strong reaction to the administration’s anti-DEI executive order. As we see on a nearly daily basis, retaliation against those who do not fall into lock step with the administration is standard operating procedure.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In